Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation 
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
Ford Takes $19.5 Billion Charge as EV Strategy Shifts Toward Hybrids 
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide 
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio 
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute 
BRISBANE, Calif., Aug. 15, 2017 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Peter Maag, PhD., Chief Executive Officer, and Michael Bell, Chief Financial Officer, will be participating in four upcoming investor conferences.
Piper Jaffray Bus Tour in Palo Alto, CA
- Dr. Peter Maag and Michael Bell will participate on Wednesday, August 23, 2017
at 9:30am PT/12:30pm ET
Southern California Investor Conference in Newport Beach, CA
- Dr. Peter Maag will present on Thursday, August 24, 2017 at 10:30am PT/1:30pm ET
Rodman & Renshaw 19th Annual Global Investment Conference in New York City
- Dr. Peter Maag will present on Monday, September 11, 2017 at 12:00pm PT/3:00pm ET
Cantor Fitzgerald Global Healthcare Conference in New York City
- Dr. Peter Maag will present on Tuesday, September 26, 2017 at 12:25pm PT/3:25pm ET
Live audio webcasts of Southern California Investor, Rodman & Renshaw Global Investment and Cantor Fitzgerald Global Health conferences will be available online from the investor relations page of the Company's website at http://investors.caredxinc.com. The webcast replays of the presentations will begin approximately one hour after the conclusion of the live presentations and will be available on the Company's website for 90 days. Due to the one-on-one only format of the Piper Jaffray Bus Tour, no webcast will be available.
About CareDx
CareDx, Inc., headquartered in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant recipients. CareDx offers products across the transplant testing continuum, including AlloMap® and AlloSure™ for post-transplant surveillance and Olerup SSP®, Olerup QTYPE®, and Olerup SBT™ for pre-transplant HLA testing.
For more information, please visit: www.CareDx.com.
Investor Contact Sasha King, Chief Commercial Officer T: +1 415-287-2393 E: [email protected]
